Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -105,584 | -78,425 | -50,007 | -24,179 | -93,961 |
| Depreciation Amortization | 4,697 | 3,472 | 2,250 | 1,090 | 2,932 |
| Accounts payable and accrued liabilities | 8,821 | 8,530 | 2,670 | 2,835 | -8,044 |
| Other Working Capital | -1,018 | 2,839 | -6,047 | -2,105 | 4,796 |
| Other Operating Activity | 2,356 | -202 | 3,013 | 146 | 16,068 |
| Operating Cash Flow | $-90,728 | $-63,786 | $-48,121 | $-22,213 | $-78,209 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,433 | 626 | -7,892 | -24,672 | -19,469 |
| Investing Cash Flow | $12,433 | $626 | $-7,892 | $-24,672 | $-19,469 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 75,001 | 75,001 | 74,897 | 74,560 | 135,919 |
| Other Financing Activity | -284 | 900 | 2,084 | -1,074 | 375 |
| Financing Cash Flow | $74,717 | $75,901 | $76,981 | $73,486 | $136,294 |
| Beginning Cash Position | 57,466 | 57,466 | 57,466 | 57,466 | 18,850 |
| End Cash Position | 53,888 | 70,207 | 78,434 | 84,067 | 57,466 |
| Net Cash Flow | $-3,578 | $12,741 | $20,968 | $26,601 | $38,616 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,728 | -63,786 | -48,121 | -22,213 | -78,209 |
| Free Cash Flow | -90,728 | -63,786 | -48,121 | -22,213 | -78,209 |